Related Experiment Video

Updated: May 23, 2025

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
06:51

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Published on: July 21, 2018

17.5K

Uncovering the rewired IAP-JAK regulatory axis as an immune-dependent vulnerability of LKB1-mutant lung cancer

Changfa Shu1,2, Jianfeng Li1, Jin Rui3

  • 1Department of Pharmacology and Chemical Biology, Emory University School of Medicine, Atlanta, GA, USA.

Nature Communications
|March 8, 2025
PubMed

Insights

Lung cancer cells with LKB1 mutations evade immune attack by relying on IAP proteins. Inhibiting IAP restores anti-tumor immunity, offering a new immunotherapy strategy for these difficult-to-treat tumors.

Area of Science:

  • Oncology
  • Immunology
  • Molecular Biology

Background:

  • Genomic alterations in tumors allow cancer cells to evade immune surveillance, leading to immunotherapy failure.
  • Understanding the molecular mechanisms behind therapeutic resistance is crucial for developing effective precision immunotherapy strategies.

Purpose of the Study:

  • To identify molecular determinants of immune response in LKB1-mutant lung cancer.
  • To explore the potential of targeting the LKB1-IAP-JAK1 complex to overcome immune resistance.

Main Methods:

  • Identification of the Liver Kinase B1 (LKB1)-Inhibitor of Apoptosis Protein (IAP)-Janus Kinase 1 (JAK1) dynamic complex.
  • Pharmacological inhibition of IAP in an LKB1-mutant mouse model.
  • Assessment of STING expression, DNA sensing signaling, and immune cell infiltration.

Main Results:

  • LKB1 alterations create a dependency on IAP for immune resistance in lung cancer cells.
  • IAP inhibition restores JAK1-regulated STING expression and DNA sensing.
  • Pharmacological IAP inhibition enhances cytotoxic immune cell infiltration and anti-tumor activity.

Conclusions:

  • The LKB1-IAP-JAK1 complex is a key regulator of immune response in LKB1-mutant lung cancer.
  • Targeting IAP-JAK1 interactions may re-sensitize immunologically cold LKB1-mutant tumors to immunotherapy.
  • IAP inhibitors represent a promising therapeutic strategy for enhancing precision immunotherapy.

More Related Videos

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma10:21

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma

Published on: September 20, 2024

365
A Method for Screening and Validation of Resistant Mutations Against Kinase Inhibitors12:40

A Method for Screening and Validation of Resistant Mutations Against Kinase Inhibitors

Published on: December 7, 2014

14.8K

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
8.6K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
5.9K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.4K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.7K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.2K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K